What does line of credit outstanding mean?

This represents the total principal amount currently drawn and outstanding under a revolving credit facility or similar short-term borrowing arrangement. It serves as a measure of the company's reliance on external debt financing to support its working capital needs or bridge operational funding gaps. Investors use this to evaluate the company's leverage position and its access to liquidity beyond equity-based financing.

Kyverna Therapeutics, Inc. KYTX Line of Credit Outstanding

Line of Credit Outstanding at other companies

Postal Realty TrustPSTL

$49M+104%

Ironwood PharmaceuticalsIRWD

$385M0.0%

Marathon Digital HoldingsMARA

$150M-50.0%

Hyster-Yale Materials Handling, Inc.HY

$108M+9.6%

Maui Land & PineappleMLP

$6.5M+117%

Karman Holdings Inc.KRMN

$0-100%

Other financials

Income statement

See full

Operating income-$41.4M+12.7%

Net income-$39.7M+11.0%

EPS (diluted)-$0.66+35.9%

Balance sheet

See full

Cash & equivalents$32.2M-43.4%

Total debt$9.2M+32.1%

Total equity$195.6M-12.7%

Total assets$257.0M-1.4%

Cash flow

See full

Operating cash flow-$41.6M+7.4%

CapEx$2.0K-98.0%

Free cash flow-$33.5M+10.8%

Valuation

See full

Market cap$498.52M+276%

Enterprise value$475.49M+475%

Returns & leverage

See full

Return on equity-74.5%+74.4pp

Debt / equity0×0.0×

Current ratio8.1×+0.7×

Where this comes from

Reported directly by Kyverna Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LongTermLineOfCredit.

The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kyverna Therapeutics, Inc.'s line of credit outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kyverna Therapeutics, Inc.'s line of credit outstanding?: Kyverna Therapeutics, Inc. (KYTX) reported line of credit outstanding of $24.81M in Q1 2026.
What does line of credit outstanding mean?: This represents the total principal amount currently drawn and outstanding under a revolving credit facility or similar short-term borrowing arrangement. It serves as a measure of the company's reliance on external debt financing to support its working capital needs or bridge operational funding gaps. Investors use this to evaluate the company's leverage position and its access to liquidity beyond equity-based financing.